City of Columbus Awards Financial Services Contract to Hikma Pharmaceuticals USA Inc (June 2026)
- Approved
- Jun 29, 2026
- Term
- up to 6 years
The 30-second brief
Council approved a six-year, 45% Job Creation Tax Credit Agreement with Hikma Pharmaceuticals USA Inc., supporting a $215.7 million expansion, 50 new jobs, and over 1,200 retained positions.
Hikma Pharmaceuticals USA Inc holds this financial services contract with City of Columbus. Its other public contracts on record include work for City of Bedford and Pharmaceutical and Therapeutics Committee | State of Connecticut.
Term as filed: up to 6 years.
See who decides the next one before it's bid.
Get pre-RFPs freeFree account · 30-second setup · No credit card
Contract details
- Contract type
- Financial Services
- Document date
- June 29, 2026
- Term
- up to 6 years
- Agency
- City of Columbus
- Source document
- City of Columbus Agenda Final Revised 2026-06-29 (Agenda)
Hikma Pharmaceuticals USA Inc's other public contracts
More City of Columbus contracts
Questions about this contract
Who was awarded the financial services contract by City of Columbus?
Hikma Pharmaceuticals USA Inc was awarded this financial services contract by City of Columbus, as recorded on June 29, 2026.
What type of contract is this?
This is a Financial Services contract, documented as a agenda record.
Where was this contract approved?
This contract appears in City of Columbus Agenda Final Revised 2026-06-29 (Agenda), dated June 29, 2026 from City of Columbus. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does Hikma Pharmaceuticals USA Inc hold?
Hikma Pharmaceuticals USA Inc may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is City of Columbus currently buying?
Explore City of Columbus's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.